Download MendeleyDe novo fragment design: a medicinal chemistry approach to fragment-based lead generation.
Talamas, F.X., Ao-Ieong, G., Brameld, K.A., Chin, E., de Vicente, J., Dunn, J.P., Ghate, M., Giannetti, A.M., Harris, S.F., Labadie, S.S., Leveque, V., Li, J., Lui, A.S., McCaleb, K.L., Najera, I., Schoenfeld, R.C., Wang, B., Wong, A.(2013) J Med Chem 56: 3115-3119
- PubMed: 23509929
- DOI: https://doi.org/10.1021/jm4002605
- Primary Citation of Related Structures:
4IH5, 4IH6, 4IH7 - PubMed Abstract:
The use of fragments with low binding affinity for their targets as starting points has received much attention recently. Screening of fragment libraries has been the most common method to find attractive starting points. Herein, we describe a unique, alternative approach to generating fragment leads. A binding model was developed and a set of guidelines were then selected to use this model to design fragments, enabling our discovery of a novel fragment with high LE.
Organizational Affiliation:
Hoffmann-La Roche Inc, Pharma Research & Early Development, 340 Kingsland Street, Nutley, New Jersey 07110, United States. franciscotalamas@gmail.com
